Claims for Patent: 5,215,895

✉ Email this page to a colleague

Summary for Patent: 5,215,895

Title:	DNA encoding a mammalian cytokine, interleukin-11
Abstract:	A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system.
Inventor(s):	Bennett; Frances K. (Melrose, MA), Paul; Stephen R. (Boston, MA), Yang; Yu-Chung (Indianapolis, IN)
Assignee:	Genetics Institute, Inc. (Cambridge, MA)
Application Number:	07/526,474
Patent Claims:	1. An isolated DNA sequence that codes an expression for an amino acid sequence selected from the group consisting of: (a) amino acid 21 through amino acid 199 of the primate sequence of FIG. 3; (b) amino acid 21 through amino acid 199 of the human sequence of FIG. 3; (c) amino acid 1 through amino acid 199 of the primate sequence of FIG. 3; and (d) amino acid 1 through amino acid 199 of the human sequence of FIG. 3. 2. An isolated DNA sequence that codes on expression for an amino acid sequence comprising amino acid 21 through amino acid 199 of the human sequence of FIG. 3. 3. A DNA sequence that codes on expression for an amino acid sequence comprising amino acid 1 through amino acid 199 of the human sequence of FIG. 3. 4. A plasmid vector comprising a DNA sequence of claim 1 or claim 2. 5. A cell transformed with a DNA sequence of claim 1 or claim 2 in operative association with an expression control sequence capable of directing replication and expression of said DNA sequence. 6. The cell according to claim 5 wherein the cell is a mammalian or bacterial cell. 7. A process for producing an IL-11 protein comprising culturing a cell of claim 5 in a suitable culture medium and isolating said I1-11 protein from said cell.

Details for Patent 5,215,895

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Wyeth Pharmaceuticals Inc.	NEUMEGA	oprelvekin	For Injection	103694	November 25, 1997	⤷ Subscribe	2010-06-01
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,215,895

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9107495	⤷ Subscribe
United States of America	6066317	⤷ Subscribe
United States of America	5854028	⤷ Subscribe
United States of America	5700664	⤷ Subscribe
United States of America	5371193	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.